Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 11/2005

01-11-2005 | Laboratory Investigation

Evaluation of serum leptin concentration in Behçet’s disease with ocular involvement

Authors: Sevim Kavuncu, Feray Koç, Melih Kurt, Buğra Eryüksel, Serap Ortaç, Pınar Özdal, Esin Fırat

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 11/2005

Login to get access

Abstract

Purpose

To assess the correlation between the serum leptin concentration and ocular involvement in patients with Behçet’s disease.

Methods

The study included 28 male consecutive patients with Behçet’s disease ( group A, aged 19–59, median 35.5 years) and 15 male healthy control subjects ( group B, aged 25–45, median 35 years). The body mass index (BMI) was calculated for each subject at the study enrollment stage. We measured serum leptin, neutrophil count and erythrocyte sedimentation rate (ESR). Kruskal–Wallis variance analysis and the Mann–Whitney U-test were used for statistical analysis.

Results

The age and BMI between the patients with ocular Behçet’s disease and the control group were not different. White cell count and ESR values were found to be significantly higher among patients with Behçet’s disease and ocular involvement (p<0.001). The median serum leptin concentrations were as follows: group A: 2.66 (0.57–7.02 ng/ml) and in group B: 2.55 (1.55–7.82 ng/ml). There was no statistically significant difference between the groups.

Conclusion

Serum leptin level does not correlate with ocular involvement in patients with Behçet’s disease.
Literature
1.
go back to reference Anders HJ, Rihi M, Heufelder A, Loch A, Schattenkirchner M (1999) Leptin levels are not correlated with disease activity in patients with rheumatoid artritis. Metabolism 48:745–748CrossRefPubMed Anders HJ, Rihi M, Heufelder A, Loch A, Schattenkirchner M (1999) Leptin levels are not correlated with disease activity in patients with rheumatoid artritis. Metabolism 48:745–748CrossRefPubMed
2.
go back to reference Benezra D, Cohen E (1986) Treatement and visual prognosis in Behçet’s disease. Br J Ophthalmol 70:589–592PubMedCrossRef Benezra D, Cohen E (1986) Treatement and visual prognosis in Behçet’s disease. Br J Ophthalmol 70:589–592PubMedCrossRef
3.
go back to reference Bloch-Michel E, Nussenblatt RB (1987) International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 103:234–235PubMed Bloch-Michel E, Nussenblatt RB (1987) International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 103:234–235PubMed
4.
go back to reference Evereklioglu C, İnalöz HS, Kırtak N, Doganay S, Bulbul M, Ozerol E, Er H, Ozbek E (2002) Serum leptin concentration is increased in patients with Behçet’s syndrome and is correlated with disease activity. Br J Dermatol 147:331–336CrossRefPubMed Evereklioglu C, İnalöz HS, Kırtak N, Doganay S, Bulbul M, Ozerol E, Er H, Ozbek E (2002) Serum leptin concentration is increased in patients with Behçet’s syndrome and is correlated with disease activity. Br J Dermatol 147:331–336CrossRefPubMed
5.
go back to reference Hernandez C, Simo R, Chacon P, Sabin P, Baena JA, Castellanos JM, Planas M (2000) Influence of surgical stress and parenteral nutrition on serum leptin concentration. Clin Nutr 19(1):61–64CrossRefPubMed Hernandez C, Simo R, Chacon P, Sabin P, Baena JA, Castellanos JM, Planas M (2000) Influence of surgical stress and parenteral nutrition on serum leptin concentration. Clin Nutr 19(1):61–64CrossRefPubMed
6.
go back to reference Honigmann S, Nath A, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Flores-Riveros CR (1998) Biological action of leptin as an angiogenetic factor. Science 281:1683–1686CrossRefPubMed Honigmann S, Nath A, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Flores-Riveros CR (1998) Biological action of leptin as an angiogenetic factor. Science 281:1683–1686CrossRefPubMed
7.
go back to reference International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080 International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
8.
go back to reference Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM (1998) Leptin regulates proinflammatory immune responses. FASEB J 12:57–65PubMed Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM (1998) Leptin regulates proinflammatory immune responses. FASEB J 12:57–65PubMed
9.
go back to reference Maruna P, Gürlich R, Fasko R, Haluzik M (2001) Serum leptin levels in septic men correlate well with serum reactive protein and TNF-alpha but not BMI. Physiol Res 50:589–594PubMed Maruna P, Gürlich R, Fasko R, Haluzik M (2001) Serum leptin levels in septic men correlate well with serum reactive protein and TNF-alpha but not BMI. Physiol Res 50:589–594PubMed
10.
go back to reference Nussenblatt RB (1997) Uveitis in Behçet’s disease. Int Rev Immunol 14:67–79PubMed Nussenblatt RB (1997) Uveitis in Behçet’s disease. Int Rev Immunol 14:67–79PubMed
11.
go back to reference Ohno S, Odhuchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M (1982) Close association of HLA-B51 with Behçet’s disease. Arch Ophthalmol 100:1455–1458PubMed Ohno S, Odhuchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M (1982) Close association of HLA-B51 with Behçet’s disease. Arch Ophthalmol 100:1455–1458PubMed
12.
go back to reference Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet’s disease. N Engl J Med 21:1284–1291CrossRef Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet’s disease. N Engl J Med 21:1284–1291CrossRef
13.
go back to reference Santos-Alvarez J, Gaberna R, Sanchez-Margelat V (1999) Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 199:6–11CrossRef Santos-Alvarez J, Gaberna R, Sanchez-Margelat V (1999) Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 199:6–11CrossRef
14.
go back to reference Takahashi N, Waelput W, Guisey Y (1999) Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med 189:207–212CrossRefPubMed Takahashi N, Waelput W, Guisey Y (1999) Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med 189:207–212CrossRefPubMed
15.
go back to reference Winters B, Mo Z, Brooks-Asplund E, Kim S, Shoukas A, Li D, Nyhan D, Berkowitz DE (2000) Reduction of obesity as induced by leptin reverses endothelial disfunction in obese Lep(ob) mice. J Appl Physiol 89:2382–2390PubMed Winters B, Mo Z, Brooks-Asplund E, Kim S, Shoukas A, Li D, Nyhan D, Berkowitz DE (2000) Reduction of obesity as induced by leptin reverses endothelial disfunction in obese Lep(ob) mice. J Appl Physiol 89:2382–2390PubMed
Metadata
Title
Evaluation of serum leptin concentration in Behçet’s disease with ocular involvement
Authors
Sevim Kavuncu
Feray Koç
Melih Kurt
Buğra Eryüksel
Serap Ortaç
Pınar Özdal
Esin Fırat
Publication date
01-11-2005
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 11/2005
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-005-1189-7

Other articles of this Issue 11/2005

Graefe's Archive for Clinical and Experimental Ophthalmology 11/2005 Go to the issue

Announcements

Announcements